Publications by authors named "Patrice Jaillon"

Claim this Profile
A
A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.
Céline Verstuyft, Xavier Delavenne, Alexandra Rousseau, Annie Robert, Michel Tod, Patrice Jaillon

Clin Pharmacokinet· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of menopause and hormone replacement therapy with large artery remodeling.
Anne Gompel, Pierre Boutouyrie, Robinson Joannides, Sophie Christin-Maitre, Anna Kearny-Schwartz, Patrice Jaillon

Fertil Steril· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects.
Alexandra Rousseau, Fida Ayoubi, Christel Deveaux, Beny Charbit, Catherine Delmau, Patrice Jaillon

Fertil Steril· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Droperidol and ondansetron in vitro electrophysiological drug interaction study.
Jacques Weissenburger, Christian Funck-Brentano, Patrice Jaillon, Beny Charbit

Fundam Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection.
Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon

J Chromatogr B Analyt Technol Biomed Life Sci· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
Patrice Jaillon

Bull Acad Natl Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[History of the origin of Huriet-Sérusclat's law (December, 1988): protection of patients undergoing biomedical research].
Patrice Jaillon, Jean-Paul Demarez

Med Sci (Paris)· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Controlled randomized clinical trials].
Patrice Jaillon

Bull Acad Natl Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[GIP CeNGEPS, an agreement of clinical research operators to reinforce clinical trials' organisation in France].
Vincent Diebolt, Patrice Jaillon

Therapie· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart.
Laurent Monassier, Boris Manoury, Chloé Bellocq, Jacques Weissenburger, Hugues Greney, Patrice Jaillon

J Pharmacol Exp Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetic polymorphism of beta-adrenergic receptors and mortality in ischemic heart disease].
Patrice Jaillon, Tabassome Simon

Therapie· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters.
Emmanuelle Comets, Céline Verstuyft, Marc Lavielle, Patrice Jaillon, Laurent Becquemont

Eur J Clin Pharmacol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical pharmacology: from review to planning.
Régis Bordet, Pascale Jolliet, Patrice Jaillon

Therapie· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching basic and clinical pharmacology to medical students: a 2006 survey in French schools of medicine.
Patrice Jaillon

Therapie· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian population.
Claire Larramendy-Gozalo, Jue Quin Yang, Céline Verstuyft, Laurent Bodin, Liliane Dubert, Patrice Jaillon

Basic Clin Pharmacol Toxicol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental and genetic factors associated with morphine response in the postoperative period.
Laurent Coulbault, Marc Beaussier, Céline Verstuyft, Henri Weickmans, Liliane Dubert, Patrice Jaillon

Clin Pharmacol Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
Jean-Marie Poirier, Jean-Baptiste Guiard-Schmid, Jean-Luc Meynard, Philippe Bonnard, Ouahiba Zouai, Patrice Jaillon

AIDS· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacogenetic testing: utility in drug development and in routine clinical practice].
Patrice Jaillon

Bull Acad Natl Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacogenetics and interindividual variability in drug response: cytochrome P-450 2C9 and coumarin anticoagulants].
Laurent Becquemont, Céline Verstuyft, Patrice Jaillon

Bull Acad Natl Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs.
Muriel Vray, Bernard Hamelin, Patrice Jaillon,

Therapie· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir.
Jean-Baptiste Guiard-Schmid, Jean-Marie Poirier, Philippe Bonnard, Jean-Luc Meynard, Laurence Slama, Patrice Jaillon

AIDS· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.
Lina Quteineh, Celine Verstuyft, Christelle Descot, Liliane Dubert, Annie Robert, Patrice Jaillon

Thromb Haemost· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.
Laurent Bodin, Céline Verstuyft, David-Alexandre Tregouet, Annie Robert, Liliane Dubert, Patrice Jaillon

Blood· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon

Ther Drug Monit· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of malnutrition on cytochrome P450 1A2 activity in elderly patients.
Brigitte Hamon-Vilcot, Tabassome Simon, Laurent Becquemont, Jean-Marie Poirier, François Piette, Patrice Jaillon

Therapie· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis